About this trial
The research question is whether a single fraction of preoperative radiosurgery can reduce the incidence of leptomeningeal disease 12 months following resection of a brain metastasis (BM) as compared with 5 fractions of postoperative stereotactic radiotherapy.
Eligibility criteria
Qualifiers
Provision of signed and dated informed consent form
Stated willingness to comply with all study procedures and availability for the duration of the study
Age ≥18
Karnofsky performance status ≥60
Disqualifiers
Radiosensitive histology: germ cell tumour, lymphoma, multiple myeloma
>10 mm midline shift, effacement of the 4th ventricle or other sign of raised intracranial pressure requiring urgent decompressive surgery
More than 4 brain metastases or the diameter of the metastasis for resection >4.0 cm.
More than 1 metastasis requiring resection
Trial design
Treatments tested in this trial
- preoperative radiosurgery
- postoperative hypofractionated stereotactic radiotherapy